Issue Date: August 11, 2014
Metabolix And Gevo Raise Needed Funds
Biobased chemical firms Metabolix and Gevo are working to raise additional financing. Metabolix says it has entered a private placement agreement with investors as well as some members of its board and management team for equity worth $25 million. Earlier in the year the firm said it hopes to raise at least $50 million to secure capacity for its polyhydroxyalkanoate polymers. Meanwhile, Gevo says it will sell $18 million worth of common stock . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society